This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
Wednesday, December 12, 2012
The Most Beautiful Gift of All...the Gift of Life
“What a great Christmas present!” Those are the words that American Liver Foundation supporter and liver disease survivor Winn Stephenson uses to describe his lifesaving liver transplant that took place on December 22, 2010.
Winn’s life altering journey began in 1985. He was at the top of his game and it seemed as though nothing could stop him. Then, the results from a routine physical indicated his liver levels were off the charts. Blindsided. The unexpected had happened and thus began Winn’s battle with liver disease. Watch the video above to hear Winn’s story in his own words.
http://go.liverfoundation.org/site/PageServer?pagename=2012_EOY_Winn_Stephenson
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment